Get started
Author

A.M. Frezza

Observed names: A M Frezza, AM Frezza, Frezza, A.M.
OpenAlex ID: A5031046292
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
2018 · P G Casali, N Abecassis, et al. · PubMed · 117
SELNET clinical practice guidelines for bone sarcoma
2022 · JY Blay, E. Palmerini, et al. · Critical Reviews in Oncology/Hematology · 33
PDF
Corrigendum to “SELNET clinical practice guidelines for soft tissue sarcoma and GIST” [Cancer Treat. Rev. 102 (2021) 102312]
2023 · J.Y. Blay, N. Hindi, et al. · Cancer Treatment Reviews · 5
PDF
Corrigendum to “SELNET clinical practice guidelines for bone sarcoma” Critical reviews in oncology/hematology, vol. 174 (2022), 1–10
2022 · J.Y. Blay, E. Palmerini, et al. · Critical Reviews in Oncology/Hematology · 2
Tazemetostat and doxorubicin in patient-derived preclinical models of epithelioid sarcoma (ES)
2022 · S. Pasquali, N. Arrighetti, et al. · European Journal of Cancer · 2
PDF
Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group network
2026 · G.G. Baldi, A.M. Frezza, et al. · ESMO Open · 1
256eP Sarcomas in PTEN hamartoma tumor syndrome: Case description and updated literature review
2026 · G. Rebecchi, P. di Mauro, et al. · ESMO rare cancers.
2732P Comparison between RECIST v1.1 and pain assessment criteria (PAC) in epithelioid hemangioendothelioma (EHE)
2025 · L. Zambelli, G. Tinè, et al. · Annals of Oncology
236 (PB224): Tazemetostat and doxorubicin combined treatment in patient-derived preclinical models of epithelioid sarcoma
2024 · C. Soffientini, N. Arrighetti, et al. · European Journal of Cancer
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
2018 · P G Casali, N Abecassis, et al. · PubMed
Works count: 12
Citation count: 165
H-index: 4
I10-index: 2
Year
Topic
Type